Trial · NCT00856284
Results by group123
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 123
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 52 | Metformin + Alogliptin 12.5 mg | -0.81 | Standard Error 0.027 | percentage glycosylated hemoglobin | |
| Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 52 | Metformin + Alogliptin 25 mg | -0.76 | Standard Error 0.027 | percentage glycosylated hemoglobin | |
| Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 52 | Metformin + Glipizide | -0.73 | Standard Error 0.029 | percentage glycosylated hemoglobin | |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 12.5 mg | Week 4 (n=341, 354, 318) | -0.37 | Standard Error 0.020 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 25 mg | Week 4 (n=341, 354, 318) | -0.40 | Standard Error 0.020 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Glipizide | Week 4 (n=341, 354, 318) | -0.41 | Standard Error 0.021 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 12.5 mg | Week 8 (n=370, 382, 336) | -0.56 | Standard Error 0.024 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 25 mg | Week 8 (n=370, 382, 336) | -0.60 | Standard Error 0.024 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Glipizide | Week 8 (n=370, 382, 336) | -0.66 | Standard Error 0.025 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 12.5 mg | Week 12 (n=371, 382, 336) | -0.69 | Standard Error 0.025 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 25 mg | Week 12 (n=371, 382, 336) | -0.71 | Standard Error 0.025 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Glipizide | Week 12 (n=371, 382, 336) | -0.78 | Standard Error 0.026 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 12.5 mg | Week 16 (n=371, 382, 336) | -0.74 | Standard Error 0.026 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 25 mg | Week 16 (n=371, 382, 336) | -0.76 | Standard Error 0.025 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Glipizide | Week 16 (n=371, 382, 336) | -0.78 | Standard Error 0.027 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 12.5 mg | Week 20 (n=371, 382, 336) | -0.76 | Standard Error 0.026 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 25 mg | Week 20 (n=371, 382, 336) | -0.78 | Standard Error 0.025 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Glipizide | Week 20 (n=371, 382, 336) | -0.79 | Standard Error 0.027 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 12.5 mg | Week 26 (n=371, 382, 336) | -0.80 | Standard Error 0.027 | percentage of glycosylated hemoglobin |
| Change From Baseline in Glycosylated Hemoglobin at Other Time Points | Metformin + Alogliptin 25 mg | Week 26 (n=371, 382, 336) | -0.79 | Standard Error 0.026 | percentage of glycosylated hemoglobin |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00856284/results